Amixetrine

From Wikipedia, the free encyclopedia
Amixetrine
Amixetrine.png
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 1-[2-(3-methylbutoxy)-2-phenylethyl]pyrrolidine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC17H27NO
Molar mass261.409 g·mol−1
3D model (JSmol)
  • O(CCC(C)C)C(c1ccccc1)CN2CCCC2
  • InChI=1S/C17H27NO/c1-15(2)10-13-19-17(14-18-11-6-7-12-18)16-8-4-3-5-9-16/h3-5,8-9,15,17H,6-7,10-14H2,1-2H3 checkY
  • Key:ISRODTBNJUAWEJ-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  

Amixetrine (INN) (brand name Somagest; developmental code name CERM-898) is a drug that was formerly marketed in France but is now no longer sold.[1][2] According to various sources it has been said to be an anti-inflammatory, antidepressant, antispasmodic, anticholinergic, antihistamine, and antiserotonergic, but its definitive indications and pharmacology are unclear.[1][2] The drug was first synthesized in 1969 and was introduced in France in 1972.[1][2]

References[]

  1. ^ a b c Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 80–. ISBN 978-1-4757-2085-3.
  2. ^ a b c William Andrew Publishing (22 October 2013). "Amixetrine Hydrochloride". Pharmaceutical Manufacturing Encyclopedia (3rd ed.). Elsevier. pp. 285–. ISBN 978-0-8155-1856-3.


Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by .

  • v
  • t
Retrieved from ""